Creatine is being studied as one possible addition to resistance training in midlife and later life. Research involving postmenopausal women suggests it may help some strength and lean-mass outcomes when paired with training, but results differ between trials. Evidence that creatine alone improves bone density or treats menopausal symptoms is lacking. Women in their early 40s, women after menopause and adults over 55 are different populations; findings from one should not be presented as a guarantee for the others
|
Population |
Intervention |
What was found |
|
Postmenopausal women, seven trials pooled |
Creatine, often alongside resistance training |
A 2026 review found small lean-mass and strength gains, particularly with at least 5 g daily plus training; it did not establish bone-density benefit. |
|
237 postmenopausal women, mean age 59 |
Weight-based creatine or placebo plus exercise for two years |
No improvement in primary bone mineral density outcome; some femoral-neck geometry measures favoured creatine. |
|
200 postmenopausal women with osteopenia |
3 g daily or placebo for two years |
No improvement in bone measures, lean mass or muscle function without a structured resistance-training intervention. |
|
Older adults in mixed-sex trials |
Creatine plus resistance training versus training alone |
Meta-analyses often report modest additional strength or lean-mass gains; these are not women-only estimates. |
These studies differ in age, training, dose and outcome measures. A positive finding for strength does not prove a benefit for bone, and a change in lean mass is not the same thing as a demonstrated reduction in falls or fractures. The studies and their limitations are discussed below.
Creatine helps regenerate adenosine triphosphate, or ATP, during brief, repeated bouts of intense muscular effort. It is produced in the body and obtained in small amounts from foods such as meat and fish. A supplement raises muscle creatine stores over time, which may support repeated training efforts. This established mechanism explains interest in creatine when women are thinking about how to keep exercising regularly in midlife.
Public discussion sometimes runs far ahead of the evidence. Creatine is not a replacement for strength training, sufficient food, sleep or clinical care. Nor is it a hormone treatment. Its best-supported exercise application concerns successive bursts of short-term, high-intensity activity. For the broader picture, read our guide to creatine for women and the separate explanation of creatine monohydrate benefits.
Ageing can bring gradual changes in muscle size, strength and power, but they do not begin at an identical age or proceed at a fixed rate for everyone. Activity level, training history, health, diet and life circumstances all matter. A woman turning 40 does not suddenly need a supplement because of a birthday. The more useful question is whether she has a realistic way to keep using and challenging her muscles.
The menopausal transition is another reason this topic comes up, though midlife experiences vary. Some research describes changes in body composition around this time, but it is difficult to separate hormonal changes from ageing and changes in activity in every study. Resistance exercise remains a practical foundation because it gives muscles a reason to adapt. Creatine may be considered as an adjunct to that work; it cannot reproduce the training stimulus by itself.
Muscle strength also matters for ordinary tasks such as rising from a chair, carrying shopping and climbing stairs. Studies often measure a one-repetition maximum or lean tissue on a scan, which are useful research outcomes but do not automatically translate into a noticeable change in daily life. Keeping that distinction in mind helps make sense of both promising and disappointing headlines.
The clearest question is whether adding creatine to a resistance-training programme improves outcomes compared with the same training plus placebo. A 2026 systematic review and meta-analysis focused on postmenopausal women reported small gains in lean mass and one-repetition maximum strength. Its subgroup findings were more favourable when at least 5 g per day was combined with resistance training; trials using 3 g or less without training did not show measurable gains on those outcomes. Subgroup comparisons should be read cautiously because dose and training changed together across studies.
Individual trials add context. In one small 12-week trial involving 18 older women, the creatine group improved training volume and several strength measures more than the placebo group during resistance training. A different trial involving vulnerable older women reported better appendicular lean mass and muscle function when creatine accompanied training, without a bone-mass benefit. These results are useful signals, yet small studies cannot predict an individual woman’s response.
Other reviews combine women and men of different ages. Such analyses can show whether an effect appears across older adults, but they should not be described as definitive evidence specifically for women aged 40–49. Many trials last weeks or months, use supervised exercise and select relatively healthy volunteers. There is less evidence about unsupervised use for years in people with varied health conditions.
Meta-analyses of older adults generally suggest that creatine taken alongside resistance training can add a modest improvement in strength or lean tissue compared with training alone. One 2026 analysis reported a small average strength advantage, with moderate certainty for that outcome. The average effect hides variation: the exercise programme, starting strength, duration and measures all influence what a trial can detect.
There is a separate authorised health claim for adults over 55, with specific conditions. Its wording is: “Daily creatine consumption can enhance the effect of resistance training on muscle strength in adults over the age of 55.” The stated beneficial effect requires 3 g of creatine daily alongside regular resistance training that allows workload to increase over time, at least three times weekly for several weeks, at a specified intensity. This is an over-55 claim; it must not be presented as a claim for all women over 40.
The more general authorised creatine claim concerns increased physical performance in successive bursts of short-term, high-intensity exercise and requires a daily intake of 3 g. Neither regulatory condition is an instruction that every individual should use exactly 3 g. The over-55 claim also says nothing about treatment of muscle disease. Health claims describe narrowly defined effects and conditions, while research may explore a wider range of questions without establishing a permitted marketing claim.
Bone is an important midlife concern, but the evidence for creatine improving bone mineral density is not convincing. A two-year trial in 200 postmenopausal women with osteopenia tested 3 g daily against placebo and found no improvement in bone health, lean mass or muscle function. This is especially relevant when assessing claims that creatine alone protects bones.
In another two-year trial, 237 postmenopausal women undertook resistance training and walking while taking weight-based creatine or placebo. The primary bone mineral density findings did not show the hoped-for improvement, although some measures of femoral-neck geometry favoured creatine. Bone geometry measures may be scientifically interesting, but they do not establish that the supplement prevents osteoporosis or fractures. A small positive secondary finding should not outweigh the primary result.
More studies would help establish whether certain exercise and creatine combinations have a meaningful bone effect, and whether any imaging differences lead to clinically important outcomes. For now, creatine should not be marketed as a bone-health treatment. Anyone worried about fracture risk, bone density or osteoporosis should seek assessment and advice appropriate to that concern.
A common maintenance intake is 3–5 g of creatine monohydrate each day. Some protocols begin with a loading phase of around 20 g daily, divided into smaller servings for five to seven days, followed by a maintenance intake. Loading fills muscle stores sooner, but it is not required. Studies in older women have also used weight-based amounts; those research designs are not a general instruction to copy a dose from a trial.
Age alone does not establish a different dose for every woman after 40. Three grams daily meets the condition for the authorised short-term high-intensity performance claim; the research range of 3–5 g describes common practice. A finding that some trials used at least 5 g with training does not prove that 5 g is always superior to 3 g for a particular woman. The fuller comparison is in our guide on how much creatine women should take.
If you have a kidney condition or are undergoing kidney-function testing, speak to a clinician before starting and mention creatine at any appointment. Supplemental creatine can affect blood creatinine interpretation. Evidence for routine self-directed use during pregnancy and breastfeeding is insufficient. These considerations matter more than trying to calculate a supposedly perfect dose from age alone.
Protein and creatine do different jobs. Dietary protein supplies amino acids used to build and maintain body tissues. Creatine participates in rapid energy recycling during intense efforts. Someone can consume them together; mixing creatine into a protein drink does not cancel either ingredient. A supplement does not compensate for consistently inadequate food intake or the absence of a useful exercise programme.
Resistance training can be adapted to experience and capacity: machines, free weights, resistance bands and some bodyweight movements can all offer a progressive challenge. Progression is the key idea. Over time, the work can increase in a manageable way, such as an additional repetition or a slightly heavier weight. An appropriately qualified exercise professional can help someone returning after a long break or working around a limitation.
The over-55 authorised claim has precise training conditions and must be used with those conditions. In ordinary editorial discussion, it is still sensible to keep a broader perspective: the right training plan is one that can be performed safely and repeated. There is no evidence that taking creatine while doing no resistance training gives the same muscle-strength outcome as creatine alongside progressive training.
Choose a product that clearly states its creatine amount per serving and follow its directions. The most studied form is creatine monohydrate. Take the usual serving on rest days as well as training days; muscle stores respond to sustained use rather than a narrow pre-workout window. A time you can remember, such as with breakfast, is generally more helpful than trying to optimise the minute you take it.
Thrive Creatine+ for Women is Halo’s dedicated unflavoured powder, with 5 g creatine monohydrate per daily serving. This is the primary option for someone who wants a measured 5 g creatine serving. ELEVATE Hydration + Creatine offers 3.4 g creatine in a daily sachet alongside electrolytes for someone who prefers a flavoured drink with hydration ingredients. Check the current label for all nutrients and directions, and count any creatine from other supplements before combining products.
Some people notice a small initial change on the scale as muscle stores rise and water distribution changes. It does not mean creatine has added body fat. Digestive discomfort may be more likely with large single servings; taking a usual serving with food or using a simpler maintenance routine can be more comfortable. Drink according to thirst and normal exercise needs rather than forcing an arbitrary volume of water solely because you take creatine.
It is an option for healthy women whose goals and training make it relevant, especially if they undertake resistance exercise. Age 40 alone does not create a requirement. Consider your health history and what the evidence actually covers.
Some trials in older adults and postmenopausal women suggest modest additional gains in lean mass or strength with resistance training. Results vary, and the evidence does not establish prevention or treatment of age-related muscle disease.
For the muscle outcomes discussed here, evidence is stronger when creatine accompanies resistance training. A two-year trial of 3 g daily in postmenopausal women with osteopenia did not improve lean mass or muscle function without that structured training approach.
Three to five grams of creatine monohydrate daily is a commonly studied maintenance range, not personalised medical dosing. Trials use other protocols too. Check the pack directions and seek individual advice if you have a relevant health concern.
A small early increase in scale weight can reflect water held within muscle as creatine stores rise. That is different from body fat gain. Responses differ and the scale cannot tell you exactly what changed.
Yes. They serve different roles and can be taken in the same drink or meal. The key is to follow the serving directions for each product and consider total dietary intake.
Perimenopause itself does not establish a special creatine dose or make it a treatment for symptoms. Research specific to this transition remains limited. Healthy adults may consider it in the context of exercise, while individual health questions warrant professional advice.
Creatine may be a useful addition to a resistance-training routine for some women in midlife and later life. The strongest case is for repeated high-intensity performance and for studying strength outcomes alongside training; evidence about bone density is mixed or negative on primary outcomes. Use research involving postmenopausal women to inform the conversation, without assuming it answers every question for women in their 40s. A practical daily serving, an appropriate training plan and realistic expectations are a sounder starting point than promises about reversing ageing.
0 comments
